Commentary: Keeping the target painted for precision cancer therapy

J Thorac Cardiovasc Surg. 2021 Aug;162(2):475-476. doi: 10.1016/j.jtcvs.2020.04.095. Epub 2020 May 4.

Authors

David S Schrump¹, Chuong D Hoang²

Affiliations

¹ Thoracic Epigenetics Section, Thoracic Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Md. Electronic address: David_Schrump@nih.gov.
² Thoracic Epigenetics Section, Thoracic Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Md.

PMID: 32580902
DOI: 10.1016/j.jtcvs.2020.04.095

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Neoplasms* / therapy